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Abstract 
The phenotypic effect of some  single nucleotide  polymorphisms  (SNPs) depends on their parental  origin. We present  a 
novel  approach  to  detect  parent-of-origin  effects  (POEs) in genome-wide genotype data  of unrelated  individuals. The 
method  exploits increased  phenotypic variance in the heterozygous genotype group  relative to the homozygous groups. 
We applied  the method  to .56,000 unrelated  individuals to search for POEs influencing body mass index (BMI). Six lead 
SNPs were carried forward for replication in five family-based studies  (of ,4,000 trios). Two SNPs replicated: the paternal 
rs2471083-C allele (located near the imprinted KCNK9 gene) and the paternal  rs3091869-T allele (located near the SLC2A10 
gene)  increased  BMI  equally  (beta = 0.11 (SD), P,0.0027)  compared   to  the  respective  maternal  alleles. Real-time PCR 
experiments  of lymphoblastoid cell lines from the CEPH families showed  that expression of both genes was dependent on 
parental  origin of the  SNPs alleles (P,0.01).  Our scheme  opens  new  opportunities to  exploit  GWAS data  of unrelated 
individuals to identify POEs and demonstrates that  they play an important  role in adult obesity. 
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Introduction 
 
The effect of genetic variants on phenotypes may depend upon 
the parent from whom the variant was inherited [1,2]. Parent-of- 
origin effects (POEs) may arise through imprinting; mechanisms of 
which include cytosine methylation and histone deacetylation [2]. 
To date around 50 human genes are known to be imprinted and 
for  most  mammalian  species less than  1%  of  the  genome  is 
confirmed to be imprinted [3]. One plausible explanation for this 
phenomenon  is the  parental  conflict hypothesis, whereby both 
parents would like to maximize the influence of their genome on 
their offspring [4]. Current methods for detecting parent-of-origin 
effects rely on assigning parental ancestry to the inherited alleles. 
This is straightforward in linkage studies, which have identified 
potential POEs on type 2 diabetes, body mass index (BMI) [5,6], 
and alcohol intake [7–9]. However, only a very few of these findings 
have been replicated and the identified linkage peaks often span 
large chromosomal regions harbouring hundreds of genes, hence 
the  causal gene or  regulatory sequence is unknown. A notable 
exception is the work of Kong et al [1] who inferred parental origin 
through genealogy information and long-range phasing to subse- 
quently test for POEs. This study identified six SNPs, four 
associated with risk of type 2 diabetes and the other two associated 
with each of breast cancer and basal-cell carcinoma. 
Genome-wide association studies (GWASs) of unrelated  indi- 
viduals have very precisely identified a large number of genetic loci 
harbouring SNPs whose (alternative) allele counts associate with 
common traits. Since GWASs predominantly  include unrelated 
individuals, the parental origin of the alleles cannot be determined, 
hence genetic effects influenced by the parental origin of the alleles 
are typically not considered. Here we present a novel approach 
that is able to detect POEs using genome-wide genotype data of 
unrelated individuals. We chose BMI as our target trait, due to 
Forsythe test, modified to test the mean absolute deviations from the 
median in the heterozygous and homozygous groups (see Materials 
and Methods for details). We applied this test to BMI values 
(corrected for age and age-squared), separately in men and women, in 
15 studies, totalling up to 56,092 individuals (detailed description of 
the cohorts can be found in Tables S1–S3), 13 of which participated 
in previous meta-analyses of the GIANT consortium [10]. In total 
2,673,768 HapMap imputed and genotyped SNPs were tested. For 
each locus, a lead SNP (with the strongest POE  association)  was 
identified;  other  markers  within 1 Mb  or  in  LD  (r2.0.1)  were 
excluded from  further  investigations. Sex-specific association sum- 
mary statistics were then meta-analysed. No sex specific difference in 
effects were observed, therefore all reported results are sex-combined. 
Our criteria to select SNPs to take forward to the replication stage 
resulted in the selection of six independent SNPs: four lead SNPs 
with POE P-value ,561026  and three SNPs in imprinted regions 
with P,561024  (see Fig S1 for QQ-plot), one SNP fulfilled both 
criteria. See Table 1 for details of these results and Materials and 
Methods for details of the applied selection methods. These six 
SNPs were carried forward to the replication stage. 
 
Replication in family-based studies 
The replication stage utilised five family-based  studies (see Tables 
S1–S3) to test for parent-of-origin effects at the six selected SNPs. 
Only  heterozygous individuals are  informative when  testing for 
parent-of-origin effects; the number of heterozygous individuals for 
each of the tested SNPs ranged from 1,122 to 4,128 (see Table 2 and 
Table S4). A simplified parental asymmetry test (PAT, see Materials 
and Methods) was applied and SNPs successfully replicated if their 
PAT P-values were below 0.0083 (Bonferroni corrected significance 
threshold for family-wise error of 0.05 with six tests). Two of these 
SNPs, rs2471083 [T/C] (GWAS  discovery BMI variance (het vs. 
27
previous findings [5,6] and the large available sample size. We 
hom):  1.058   vs   0.963,   PPOE = 9.34610 ;   replication   PAT
report the discovery of two novel loci affecting BMI in a manner 
P = 0.00264) and rs3091869 [T/C] (GWAS discovery BMI variance 
26
dependent on the parent-of-origin of the transmitted alleles. 
(het vs. hom): 1.046 vs 0.957, PPOE = 4.7610 ; replication PAT
 
Results 
 
We applied our POE test, which compares the phenotypic 
variance of the heterozygous genotype group to the variance 
observed in the  homozygous groups, to  all SNPs genome-wide. 
The test, which is applicable to unrelated individuals, assumes that an 
increased variance in the  heterozygous group  arises because the 
heterozygous group consists of two subgroups (paternal reference 
allele/maternal   alternative  allele and  maternal  reference  allele/ 
paternal alternative allele) each with different means (see Figure 1). 
Differences  in phenotypic variance were tested using the Brown- 
P = 0.00245)  successfully  replicated. In particular, we found  that 
heterozygous individuals who carry the rs2471083-C allele pater- 
nally have 0.11 (SD unit) higher BMI on average than those carrying 
the C-allele maternally (P = 0.00264). Heterozygous carriers of the 
paternal  rs3091869-C allele have 0.11 (SD unit) lower BMI on 
average than  those carrying the maternal  C-allele (P = 0.00245). 
Figure 2 shows the locuszoom plots of the POE association P-values 
for the two replicated loci (KCNK9 and SLC2A10). 
 
Impact of the discovered  variants 
By combining the effect difference estimates (bM {bP ) from the 
family-based studies and  the  marginal  association effect sizes
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Author Summary 
 
Large  genetic   association   studies   have  revealed   many 
genetic  factors  influencing  common  traits, such  as body 
mass index (BMI). These studies  assume  that  the effect of 
genetic variants is the same regardless of whether  they are 
inherited  from the  mother  or the  father. In our study, we 
have   developed  a   new   approach    that   allows  us   to 
investigate   variants   whose   impact   depends  on   their 
parental  origin (parent-of-origin effects), in unrelated 
samples when the parental  origin cannot  be inferred. This 
is  feasible  because   at  genetic   markers  at  which  such 
effects  occur  there   is  increased   variability  of  the   trait 
among  individuals who inherited  different  genetic  codes 
from their mother and their father compared  to individuals 
who inherited  the  same  genetic  code  from both  parents. 
We applied this methodology to discover genetic  markers 
with parent-of-origin effects (POEs) on BMI. This resulted in 
six candidate  markers showing strong POE association. We 
then   attempted  to  replicate  the   POE effects  of  these 
markers in family studies (where one can infer the parental 
origin  of the  inherited  variants). Two of our  candidates 
showed  significant association  in the  family studies,  the 
paternal  and maternal effects of these markers were in the 
opposite direction. 
 
 
((bM zbP )=2) from  the  largest-to-date meta-analytic  study on 
BMI [10], we estimated the effects of the maternal and paternal 
alleles. For  both  rs2471083-C  and  rs3091869-T  we  obtained 
bM ~{0:055 and  bP ~0:055. Using these effect sizes and  the 
population frequency of these SNPs, we calculated the explained 
variance of these SNPs (if their parent of origin is known) to be 
0.24%  and  0.30%  for rs2471083 and  rs3091869, respectively. 
These  effects are  comparable  to  that  of  the  strongest  BMI- 
associated variant in the FTO gene (0.34%) [10]. 
Notably, rs2471083 is located 105 kb upstream of the imprinted 
gene KCNK9. Mutations in this potassium channel gene cause 
Birk-Barel  syndrome,  a  maternally  transmitted   syndrome  of 
mental retardation, hypotonia, and unique dysmorphism, resulting 
from genomic-imprinting [11]. SNPs within 2 kb have been shown 
to be associated with HDL cholesterol, adiponectin levels [12] and 
blood pressure [13]. Its impact on hypertension is potentially via a 
mechanism  involving aldosterone,  the  concentration  of  which 
correlates strongly with fat mass. Interestingly, KCNK9 knock-out 
mice exhibited more fragmented sleep episodes [14] and 7.1%– 
9.6% increased weight gain (P = 0.02) at 19–20 weeks of age [15]. 
SNP  rs3091869  is  61 kb  upstream  of  SLC2A10,  a  glucose 
transporter involved in arterial morphogenesis. SNPs in low LD 
(in CEU r2 = 0.05) with rs3091869 have been shown to alter body 
fat distribution [16]. 
We tested these two confirmed SNPs in 705 trios with paediatric 
(extreme) obese offspring in which parental origin of the alleles was 
known in up to 255 individuals [17]. No significant effect was 
observed (see Table S5). This could be due to insufficient power, 
different genetic mechanisms between young individuals and 
adults or that our association is specific to variations within the 
range of normal BMI. 
 
Expression experiments 
We evaluated whether the parent  of origin effect of the 
rs2471083-T    and    rs3092611-T    (proxy   for    rs3091869-T, 
r2 = 0.998) alleles can be observed in the expression levels of their 
respective genes (KCNK9  or SLC2A10). To test this we carried 
out quantitative PCR  (qPCR) experiments using lymphoblastoid 
cell lines (LCL) of the CEPH families. These cell lines have been 
used extensively to identify imprinted  genes [18,19]. Using the 
available trio data we could infer the parental origin of the alleles 
of rs2471083  and  rs3092611  in  33  (9 maternal  T  alleles, 24 
paternal T  alleles) and 24 (16 maternal  T  alleles, 8 paternal T 
alleles) individuals respectively (Table S7). We performed between 
2 and 10 technical replicates per individual (mean of 7.75) and 
samples with high coefficient of variation (.5%) were discarded in 
order to ensure robustness. After quality control, 124 expression 
values from  23  (mat:pat = 4:19) samples for KCNK9  and  240 
expression values from 24  (mat:pat = 16:8) for SLC2A10  were 
available for analysis. We fitted a linear mixed model to test for 
association between expression levels (Ct values) and allelic origin. 
The  paternal  T  allele of rs2471083 was associated with lower 
KCNK9 expression levels (+1.08 [SD unit] Ct values, P = 0.0096), 
and the paternal T allele of rs3092611 was associated with higher 
SLC2A10   expression  values  (21.09   [SD   unit]   Ct   values, 
P = 0.0023). To  ensure  there  was  no  systematic bias  in  our 
experiments giving rise to spurious POE associations we repeated 
the qPCR experiments for two housekeeping genes GAPDH and 
HRPT1. Both analyses gave non-significant POE  P-values (P. 
0.3). 
 
Methylation lookups 
POEs can be driven by differences between inherited paternal 
and  maternal  methylation.  To  explore  whether  the  observed 
parent-of-origin effects at  our  discovered SNPs were driven by 
differential methylation  we  tested  whether  methylation  in  the 
regions (Chr8: 140.45–140.65 Mb  and  Chr20:  45.3–45.55 Mb) 
was (i) associated with the two respective SNPs (rs2471083, 
rs3091869) in 262 unrelated individuals from the TwinsUK cohort 
and (ii) associated with BMI in two independent cohorts: 79 BMI 
discordant (difference .0.5 SD) monozygotic twin pairs from the 
TwinsUK cohort and a sample of 412 unrelated individuals from 
the EPIC-Italy cohort. None of these analyses showed significant 
association (see Supplemental Data S1, Figures S2, S3 and Table 
S8 for further details). 
 
Discussion 
 
Our novel approach revealed two SNPs, located near the genes 
KCNK9  and  SLC2A10, influencing BMI in a  parent-of-origin 
specific fashion.  These  loci  were  the  first  and  fourth  most 
significant genome-wide  in  our  new  POE   test  for  unrelated 
individuals and both showed significant parent-of-origin effects in 
family studies. Both SNPs exhibit polar overdominance, where 
homozygous individuals have  equal  (baseline) phenotypes  and 
heterozygous genotypes confer relative risk/protection, depending 
on the parental origin. Polar overdominance, has been observed in 
humans for type2 diabetes [1] and BMI [20], however it is very 
rare and its molecular mechanism is unknown. 
RT-PCR  experiments revealed that  gene expression levels of 
KCNK9 and SLC2A10 in LCLs were also influenced in a parent- 
of-origin manner. The expression of these genes is highest in the 
brain (although it is also expressed in testis, liver, colon, adrenal 
gland and  kidney; see http://www.genecards.org/) indicating a 
potential neuronal involvement. Expression levels of KCNK9 and 
SLC2A10 in living brain cells might have been more informative 
and robust, however, such information is not available. The 
applied qPCR method was optimised to ensure that the expression 
levels measured in LCLs were representative only of the target 
transcript and amplification efficiency was assessed to be sensitive 
enough  to  allow the  detection  of even small changes in  gene 
expression. Interestingly, rs2471083  alleles, regardless of  their
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Figure 1. Explanation of the POE test. Top panel illustrates the phenotype distributions in the four genotype groups that would be observed  if 
the  parent-of-origin  of the  alleles were  known. Bottom  panel  shows  how  these  distributions  change  if the  parent-of-origin  is unobserved.  The 
resulting  heterozygous group  will have  increased  variance due  to  its heterogeneity. This example  describes  a scenario  we observe  for the  two 
replicated  hits, namely that  the  paternal-  and maternal  effects are of the  same size, but  opposite in direction (bM ~{bP ). Therefore the  average 
phenotype in the B/B group  is the same as in the A/A group, as the paternal  and maternal B allele effects cancel each other out. In the A/B group 
there  are two  subpopulations: the  A-pat/B-mat group  with phenotypic mean  of bM   and  the  A-mat/B-pat group  with bP   mean.  Thus, the  two 
subpopulations combined  also have zero mean, but increased  variance. 
doi:10.1371/journal.pgen.1004508.g001 
 
parental origin, show marginally significant association (P = 0.03) 
with KCNK9 expression levels in the hippocampus (http://www. 
broadinstitute.org/gtex/).  Our methylation analyses did not reveal 
any evidence that the POEs were driven by differences in inherited 
paternal and maternal methylation. Neither of our two SNPs tag 
common  copy  number  variants  (CNVs) (based  on  the  CNV 
reference data used in Heid et al. [21]) and we found only one 
sample (out of 14,315 available in-house, whose BMI Z-score was 
+1.18) with a 76 kb deletion overlapping rs2471083. Hence, the 
effect of the two discovered SNPs are unlikely to be driven by 
CNVs. To  check whether the two confirmed SNPs (rs3091869, 
rs2471083), or SNPs in LD (10 with r2.0.8 in 1000 Genomes 
EUR  population), show regulatory activity, we queried Regulo- 
meDB (http://regulome.stanford.edu).  None of these SNPs were 
annotated to have more than minimal binding evidence 
(RegulomeDB score below 4). 
A previous study proposed to detect POE in inbred F2 mice by a 
two-component mixture distribution fitting of the  heterozygous 
genotype group and further two components for the homozygous 
groups [22]. This method requires a parametric distribution of the 
phenotype to be assumed, small violations of this assumption can 
result in heavily biased parameter estimates. The method we chose 
is more robust to a wide range of phenotype distributions (due to 
the underlying Brown-Forsythe test employed), computationally 
faster  (making it  attractive  for  testing  millions of  SNPs) and 
applicable  to  probabilistic  genotype  calls. Our   POE  test  for 
unrelated GWAS samples is similar to a test proposed to detect 
gene-environment interactions [23] in that it exploits differences in 
phenotypic variance to detect a phenomenon not directly 
measured. Inflated phenotypic variance in the heterozygous group 
might also be the result of other  phenomenon:  (i)  a phenotype 
altering effect (be it genetic or environmental) acting only on the
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Table 1. Discovery POE association  results for the six SNPs selected  for replication. 
 
 
SNP                                                         Chr             position (B36)                   Gene (distance in kb)                        MAF              N (AA+BB)                 N (AB)                 P-value (POE)                       P-value (main) 
Genome-wide (P,5e-6) 
rs155570                                                  2                 59778667                             AC007131.1(419)                                   0.2                 32643                            15232                    2.12E-06                                  1.70E-03 
rs2471083                                               8                 140588522                           KCNK9(105)                                          0.27               33885                            22132                    9.34E-07                                  8.60E-01 
rs1345919                                               15               31961131                             AVEN(0)                                                 0.22               36850                            19142                    4.90E-06                                  5.15E-01 
rs3091869                                               20               44859324                             SLC2A10(61)                                         0.44               23891                            23143                    4.70E-06                                  3.93E-02 
Imprinted regions (P,5e-4) 
rs1398940                                               4                 90156206                             FAM13A(0)                                            0.39               25173                            22737                    4.50E-04                                  5.86E-01 
rs2471083                                               8                 140588522                           KCNK9(105)                                          0.27               33885                            22132                    9.34E-07                                  8.60E-01 
rs6500550                                               16               3686241                               TRAP1(0)                                                        0.31               27302                            20188                    1.69E-04                                  8.44E-03 
SNP matching any of the following two selection criteria were retained: (1) All lead SNPs with POE P-value below 561026. (2) All lead SNPs falling in previously reported  imprinted regions with POE P-value ,561024. Note that one 
SNP is listed twice as it met both criteria. Chr: chromosome,  Gene: nearest gene, MAF: minor allele frequency, N (AA+BB): homozygous  sample size, N (AB): heterozygous sample size, P-value (main): main effect association P-value 
in Speliotes et al. [10]. The parent  of origin P-value, ‘‘P-value  (POE)’’, is the Brown-Forsythe test P-value. SNPs marked in bold are those  which replicated  in the family studies, see Table 2. doi:10.1371/journal.pgen.1004508.t001 
 
 
 
 
 
 
Table 2. Replication of the 6 discovery SNPs in trios (or parent-offspring  pairs). 
 
 
Coded    Other                                                                                                                                                                                                beta 
SNP                   allele       allele       beta (coded paternal) - beta (coded maternal)              P-value for  beta difference                                                                 meta       P meta          N meta 
QIMR        FAMHS         FHS           ALSPAC           GS             QIMR                FAMHS            FHS                   ALSPAC           GS  
 
rs155570           G                A                0.218          20.033           20.098       0.23                   0.136          5.82E-03           7.97E-01           1.72E-01           2.43E-02           2.32E-01           0.079          5.57E-02           1646:1093 
rs1345919         A                T                     20.17         20.167           0.098          20.032              20.006       3.72E-02           2.06E-01           1.56E-01           7.15E-01           9.54E-01           20.03         4.46E-01           1231:1696 
rs1398940         G                A                0.104          0.033             0.098          20.07                0.008          1.41E-01           7.57E-01           9.50E-02           2.70E-01           9.30E-01           0.038          2.45E-01           1984:2144 
rs2471083         C                T                0.012          0.064             0.24            0.007                 0.135          8.81E-01           5.62E-01           1.48E-04           9.31E-01           1.89E-01           0.112          2.64E-03           1453:1959 
rs3091869         C                T                20.107      20.152          20.117      20.062              20.199      1.19E-01           1.29E-01           2.75E-01           3.35E-01           5.05E-02           20.112      2.45E-03           1477:1696 
rs6500550         T                     C                0.053          20.306           0.039          20.169              20.03         4.64E-01           3.14E-03           5.79E-01           2.22E-02           7.29E-01           20.057       1.08E-01           1952:1484 
 
For each target SNP, in each family we searched  for trios (or parent-offspring  pairs) with heterozygous offspring and determined the parent  of origin of the alleles (whenever possible). From each family at most one heterozygous 
offspring with known parental  origin was then  collected  and grouped according  to the parental  origin of the alleles. The equality of phenotypic means  in the two groups  was tested  using a Student  t-test  (‘‘P-value for beta 
difference column’’). The difference between the phenotypic means were meta-analysed  using inverse-variance weighting. Table notations: ‘‘beta meta’’ and ‘‘P meta’’:  meta-analysis estimate of beta (coded paternal) - beta (coded 
maternal) effect size differences and the corresponding P-value, ‘‘N meta’’: total number  of heterozygous offspring with (coded-maternal/other-paternal), (coded-paternal/other-maternal)  genotypes, respectively. 
doi:10.1371/journal.pgen.1004508.t002
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Figure 2. Local  association plots. Panels show the local POE association P-values for the KCNK9 (left panel) and SLC2A10 (right panel) loci. 
doi:10.1371/journal.pgen.1004508.g002 
heterozygous group; (ii) an overdominant effect combined with a 
genetic or  environmental  interaction  or  non-linear,  monotonic 
phenotype  transformation that  has different derivatives for low 
and high trait values;  (iii) a large marginal additive effect combined 
with a (monotonic) transformation for which the second derivative 
is maximised at the mean phenotype value of the heterozygous 
group (see Materials and Methods for details). More generally, the 
combination of the scale on which the phenotype is measured and 
a strong marginal association with an allelic dosage may give rise 
to spurious associations using variance tests [24]. Recently some 
evidence has emerged  about  loci which effect the  variance  of 
phenotypes (through impacting environmental plasticity, canali- 
zation,  developmental  stability, etc.) that  can  be  detected  via 
association with phenotypic variability [25]. Therefore, the top hits 
obtained by our POE test may need further prioritisation before 
proceeding to trio-based confirmation. We recommend the 
following checks: (a) Exclude SNPs with overdominant  effects; 
(b) For SNPs with low POE P-value, test gene-environment (GxE) 
interaction (as done in [23]) via modelling phenotypic variance as 
a function of the genotype dosage (coded in additive, recessive or 
dominant fashion). If this test is more significant than  the POE 
test, it is probably a GxE that is driving the POE association and 
also as a side effect we will observe significant difference in the 
variance between the two homozygous groups. (c) If a SNP with 
low POE P-value has marginal effect on the trait, repeat the POE 
test for various transformed versions of the phenotype such as log 
and inverse-normal quantile. If the resulting POE P-values are not 
robust, give lower priority to the examined SNP. 
For our confirmed SNPs multiple lines of evidence show that 
the  parent-of-origin  effects are  real,  most  convincingly clear 
replication in independent family data of parent-of-origin associ- 
ations of the hit SNPs with both BMI and gene expression levels. 
Further, the GWAS discovery associations are very unlikely to be 
artefacts of the factors discussed above: (i) there is no evidence of 
overdominant, additive, recessive or dominant effects (the mean 
BMI values are near identical in the three genotype groups), hence 
the signals cannot be driven by gene-environment interactions or 
be an artefact of the scale on which the phenotype is measured (ii) 
no SNP within 500 kb has any detectable marginal effect on BMI 
thus the association cannot be driven by haplotype-specific 
marginal  effects [26]; (iii)  the  phenotypic variances in the  two 
further reducing the likelihood of an artefact resulting from the 
scale on which the phenotype is measured [24]. 
Some of the negative results of the other SNPs carried forward 
to the replication phase in the family data could be explained by 
lack of power. The power to replicate POE associations in family- 
based studies is dependent on the available number of heterozy- 
gous individuals (for details see Supplemental Data S1) and thus 
increases with  minor  allele frequency (MAF). Therefore,  it  is 
unsurprising that  the two SNPs which replicated had  relatively 
high MAF (.27%). 
Linkage studies have identified four regions exerting POE  on 
BMI (10p12, 12q24, 13q32) [5] and 2q31 [27]). We looked up 
SNPs in these regions in our genome-wide discovery POE 
association results. The reported linkage regions showed enrich- 
ment for lower than  expected POE  P-values (see Figure S4 for 
regional QQ-plots), however, no SNPs survived Bonferroni 
correction. We also tried to replicate a SNP in exon 5 of DLK1 
(rs1802710) because this SNP showed polar overdominance for 
obesity in children [20], but only a very slight trend (P = 0.32) was 
visible in our study. Previously reported BMI-associated loci [10] 
show some enrichment  for lower POE  P-values (Supplemental 
Data S1, Tables S9, S10 and Figure S5), however these need to be 
replicated in family studies. 
Previous work comparing strength of associations of mother- 
offspring BMI with father-offspring BMI did not reveal intrauter- 
ine influence on obesity in children [28]. A similar conclusion was 
reached in a systematic review of seven studies [29], while stronger 
maternal  influence was observed in a recent longitudinal study 
[30]. The difference in conclusions may be due to that fact that the 
former studies included predominantly  older children than  the 
longitudinal  study (0–3.5 years). At  early  age  the  diet  of the 
offspring may be more similar to that of the mother than the father 
(e.g. due to breastfeeding), which might have contributed to the 
higher mother-offspring BMI similarity found by Linabery et al. 
[30]. 
In summary, our findings indicate that POEs may play a role in 
adult  obesity. The  two identified SNPs have  strong parent-of- 
origin  effect on  BMI,  close to  that  of the  FTO,  contributing 
substantially to the heritability of BMI. Our follow-up experiments 
demonstrated  parent-of-origin specific gene expression modula- 
tion, but failed to link methylation activity of these loci to BMI
homozygous groups, are almost identical (rs2471083: s2 ~0:96, values. Inevitably for newly discovered loci, further  studies are
s2                       2                                                                    2                            2CT ~1:06,  sTT ~0:98  and  rs3091869: sCC ~0:97,  sCT ~1:05, 
TT ~0:95);  (iv) POE  test with log- and inverse-normal quantile 
transformed  BMI values resulted in  similar results (Table S6), 
warranted to determine how these variations functionally influence 
obesity in humans. The reliance of our approach on difference in 
phenotypic variance means that it cannot be extended to binary
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outcomes. Since there are other phenomena which can give rise to 
significant POE association, we recommend that top hits from our 
method are followed up in family studies, where parental origin of 
alleles can be inferred. In addition, our variance based POE test 
for GWAS data  is naturally  much  less powerful than  actually 
testing the mean values of the two heterozygous subgroups in trios. 
However, GWASs of unrelated individuals are several-fold more 
numerous  and  typically much  larger  than  studies with  a  trio 
design,  hence  our  methodology  provides  a  great  advance  in 
parent-of-origin research by providing means to exploit all 
available GWAS data of unrelated individuals in order to identify 
parent-of-origin effects on continuous phenotypes. 
 
Materials and Methods 
In the presence of a marginal association a phenotype 
transformation could alter the genotype group variances and 
introduce  bias into  the  test [24].  For  this reason  we analysed 
untransformed  age-, age2-corrected  BMI  values (normalised to 
have zero mean and unit variance) separately for men and women. 
Standard variance tests (such as the F-test) are, however, sensitive 
to deviations from the Gaussian distribution. 
Therefore, we used a robust version of the Brown-Forsythe test. 
Briefly, we first centred the phenotype  values (at zero) in each 
genotype  group  to  avoid inflated variance  in  the  presence  of 
marginal effects in the group of all homozygote individuals. We 
denote these centred phenotypes by z, where 
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Detecting  parent  of origin effects 
If we denote the alleles of a bi-allelic SNP by ‘‘A’’ (reference) 
and ‘‘B’’ (alternative) the possible genotypes are A/A, A/B and B/ 
B. Standard  GWASs estimate the effect of the alternative allele 
dosage  on  the  phenotype  in  question.  In  this  work  we  are 
interested in associations in which a phenotype (y) is influenced by 
the  alleles of a  particular  SNP  and  the  effect depends  on  the 
parental  origin of these alleles. In  the presence of a parent-of- 
origin effect the  heterozygous genotype group  is split into two 
Here gi stands for the genotype of individual i, and mj  represents 
the median phenotype value in genotype group j, where j can take 
the  values of  AA, AB or  BB. We  then  regress the  absolute 
deviations from the median onto  a 0–1 coded genotype group 
identifier (1 for heterozygous and 0 for homozygous individuals) in 
order to estimate the POE effect size [31]. This regression result in 
a slope estimate 
 
b^~ahet {ahom ,
subgroups, depending on the parental origin of the A and B alleles. 
We  assume that  the  phenotype  of any  individual in  the  A/A 
genotype group is modelled by yAA ~mAA ze,  where mAA is the 
where ahet ~ 
X
 
i:gi ~AB 
0 
 
Dzi D=nAB  and ahom ~@ 
X 
 
i:gi ~AA 
Dzi Dz   
X
 
i:gi ~BB 
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Dzi DA
mean  and  eis an  individual  level error  with  mean  zero  and 
variance s2 . If the maternal and paternal effects of the B allele are 
bM andbP , it follows that the phenotype of an individual in the B/ 
=(nAA znBB ). The corresponding standard error is 
 
RSS 
    
nAB (nAA znBB )
B group is yBB ~(mAA zbM zbP )ze and its variance is s
2 . (Note 
that as a consequence the maternal and paternal effects of the A 
allele are {bP  and {bM .) Here we assume s
2 is constant across 
genotype groups (A/A, A/B  and B/B) and bM andbP    are fixed 
effects. The effects of violations of these assumptions are covered in 
 
 
where 
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the  discussion. The  phenotype  in the  heterozygous group  is a 
50%–50% mixture of two distributions (Fig 1a): 
RSS~ 
i 
(zi {a)
2 {b^2 nAB (nAA znBB )=n and a~ 
i 
Dzi D=n:
yAB ~mAA zpbM z(1{p)bP ze, 
 
where p is a Bernoulli random variable (with parameter K), taking 
values p~1 if the B allele is inherited from the mother and p~0 if 
inherited from the father. The heterozygous phenotype distribu- 
tion can be simplified to yAB ~(mAA zbP )zp(bM {bP )ze Since 
p  and  e  are  independent   random  variables,  the  phenotypic 
variance of the heterozygous genotype group s2    is 
 
1 
Finally, the POE P-value is assigned based on the test statistic 
b^=SEb~N (0,1).  The   test  was  extended  to  imputed  genotype 
probabilities and implemented in the latest version (v0.98) of the 
Quicktest software (http://www3.unil.ch/wpmu/sgg/quicktest/). 
The robustness of this test to deviations from normality has been 
studied in [32] and its power in [31]. 
 
SNP selection strategy 
We applied our POE test genome-wide to all HapMap imputed 
markers in  a  set of cohorts and  results were combined  across
Var(yAB )~Var(p)(bM {bP )
2 zVar(e)~ 
4 
(bM {bP )
2 zs2 cohorts using fixed-effect inverse-variance weighting meta-analy- 
sis. SNPs were selected for replication if they met at least one of the 
following two criteria: (1) POE P-value ,561026  or (2) POE P-
If a parent-of-origin effect is present bM andbP are different, value  ,561024     and   within  500 kb  of  previously  reported
thus   s2 is   larger   than   the   variance   observed   in   the imprinted regions according to the Catalogue of Parent of Origin
homozygous  groups  (s2 )   (Figure 1).  Therefore,  although  in 
regular  GWAS  data  we  cannot  identify the  two  subgroups 
within A/B genotypes, we can detect POE via increased 
phenotypic variance in the heterozygous group relative to the 
homozygous groups. 
Effects  database   (http://igc.otago.ac.nz/home.html).   At   loci 
which met either criteria, a lead SNP (with the strongest POE 
association) was identified; other markers within 1 Mb or in LD 
(r2.0.1)   were  excluded  from  further  investigations. In  total 
2,673,768 HapMap imputed and genotyped SNPs were analysed,
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of which 29,457 were considered as lying in imprinted regions, 
criterion (2). Using the procedure of Gao et al. [33] we estimated 
the effective number  of tests considered by each criterion to be 
,1,000,000 and 6,100 respectively, justifying the ,100 fold drop 
in the P-value threshold applied to the second criterion. 
 
Testing in family-based studies 
We tested our findings in family-based studies using a simplified 
parental asymmetry test [34] (PAT). For each target SNP, in each 
family we searched for trios (or parent-offspring pairs) with 
heterozygous offspring and determined the parent of origin of the 
alleles (whenever possible, i.e. at least one homozygous parent). 
From each family at most one heterozygous offspring with known 
parental origin was then collected and grouped according to the 
parental origin of the alleles. Note that although POE is acting in 
group, compared to the two homozygous groups by an appropri- 
ate  parameter   choice  for  a.   Using  a  second  order   Taylor 
expansion the variance of the transformed phenotype in the 
heterozygous group can be estimated by 
 
Var(g(yDG~AB))&g0 (m)2 s2 
 
z 
1 
g00 (m)½Var((yDG~AB)2 ){4m2 s2   
 
 
If we assume the  phenotype  follows a  Gaussian distribution 
(yDG) then, Var((yDG~AB)2 ) simplifies to 4m2 s2 z2s4  and thus 
 
1
every genotype group, it can only be detected in the heterozygous 
group. 
As at the discovery phase, we used sex-, age- and age2-corrected 
Var(g(yDG~AB))&g0 (m)2 s2 z g00 (m)2 s4 
2
BMI residuals as phenotype. The equality of phenotypic means in 
the two groups was tested using a Student t-test. When significant 
differences were detected we also estimated the difference between 
paternal and maternal effect sizes, which is simply the difference 
between the phenotype averages in the paternal- and maternal- 
groups. 
 
Effect size estimation 
In order to estimate paternal bP ) and maternal (bM ) effect  sizes 
it is sufficient to know their mean (bM zbP )=2 and their difference 
(bM {bP ). The difference between paternal and maternal effect 
alleles can also be derived from GWAS of unrelated individuals. It 
is easy to see that the test statistic defined as 
Without  loss of generality one  can  assume that  s2 ~1.  The 
variance in AA genotype group can be estimated similarly and 
thus 
 
 
Var(g(yDG~AB)){Var(g(yDG~AA)) 
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Using the special form of g(t), the variance difference can be 
expressed as 
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the absolute difference in paternal and maternal effects (DbM {bP D) 
can be estimated if the phenotypic variances in the three genotype 
groups  are  known.  However,  these  estimates will be  strongly 
subject to the winner’s curse [35], thus we used the family studies 
to derive more  reliable estimates of (bM {bP ). To  reduce  the 
effect of differences in the distribution of BMI between the family- 
based   studies,   we   meta-analysed   the   difference   estimates 
(bM {bP ) from each study in order to obtain a combined estimate 
of (bM {bP ). The average of the maternal- and paternal effects, 
(bM zbP )=2, is the association effect size using a simple additive 
genetic model, which can be most accurately estimated from the 
largest-to-date  meta-analytic  study  on   BMI   [10]   (including 
,250,000 individuals). 
 
Effect of phenotype transformation  in case of marginal 
association 
If there is an additive marginal genetic effect influencing the 
trait certain transformations may inflate the phenotypic variance 
of the heterozygous group. Let m be the phenotypic mean in the 
heterozygous group and d the marginal effect of the SNP (on the 
original  scale).  Let  g(t)   denote  an   S-shaped  transformation 
1 
function of the form 
1zea(t{m)  
that is applied to the trait.
 
In the following we show that for any d value arbitrarily large 
phenotypic variance inflation can be achieved in the heterozygous 
~a2            {f (a,d) 
16 
 
and since g0 (m{d)~g0 (mzd) and g00 (m{d)~{g00 (mzd) 
 
 
Var(g(yDG~AB)){Var(g(yDG~BB)) 
 
&Var(g(yDG~AB)){Var(g(yDG~AA)): 
 
 
It is easy to see that for a fixed d 
 
 
lim f (a,d)~0 
a?? 
 
 
As a??, f (a,d)?0 faster than a2 ??, thus for any effect size 
d we can find a transformation function g such that the variance 
inflation of the heterozygous group exceeds any arbitrary 
threshold. 
 
Cell lines, nucleic acids isolation, sequencing and qPCR 
Lymphoblastoid cell lines were derived from peripheral blood 
leukocytes of 95 members of 11 CEPH families [36] (#102, #884, 
#1333, #1340, #1341, #1345, #1346, #1347, #1362, #1408, 
#13292). They were purchased from the Coriell Cell Repository
10 
 
 
 
(http://ccr.coriell.org/), and cultured as previously described [37]. 
DNA was extracted by using the QIAamp DNA Mini kit 
(QIAGEN), and RNA by using the RNeasy Mini kit (QIAGEN), 
according  to the  manufacturer’s instructions. Primer  sequences 
were designed to amplify a 328-bp region on chromosome 8 that 
spans the rs2471083 polymorphism (forward primer: 59-ACCA- 
CAGAAGTCAGTAGACGAG-39;  reverse primer:  59-  GTGA- 
CATTGGGAGCATGGGA-39) and a 146-bp region on chromo- 
some 20 that spans the rs3092611 polymorphism (forward primer: 
59-GCCACCAGTGGTCTGATAGT-39; reverse primer: 59- 
TAACTCGTCATTCTGCCCTGG   -39).   PCR    amplification 
was  performed  in  a  25 ml   reaction  using  GoTaq   polymerase 
(Promega). After purification of PCR products (ExoSAP-IT, USB), 
sequencing reactions were carried out by using 1 ml of each of the 
3.2 mM sequencing primers and 0.5 ml of BigDye  Terminator v1.1 
(Applied Biosystems). Following on-column purification (EdgeBio), 
sequencing products were run  on an ABI-3130 XLS sequencer 
(Applied Biosystem). To synthesize cDNA, 2 mg of total RNA was 
retrotranscribed  using the  Superscript  III  reverse transcriptase 
(Invitrogen/Life  Technologies) according  to  the  manufacturer’s 
instructions and  a mix of random  hexamers and  oligo-dT that 
facilitate the  detection  of poorly expressed genes. To  validate 
primers for qPCR, we first performed a series of test amplifications 
by using a defined range of primer concentrations (50–200 nM). 
We then loaded 10 ml of each qPCR product on 1% agarose gels 
to check the specificity of the amplification product, which should 
correspond to a 113-bp (KCNK9) and 148-bp (SLC2A10) 
fragment.  To  test  KCNK9  and  SLC2A10  PCR  efficiency a 
standard  curve made  of five serial dilutions of brain  and  lung 
cDNA were used, respectively, since the two genes are known to 
be highly expressed in these organs. We obtained a standard curve 
slope of 23.49 for KCNK9 and of 23.37 for SLC2A10, 
corresponding to 94% and 98% PCR efficiency. For more details 
see Supplemental Data S1. 
 
Comparing Ct values 
The  output  of the analysis was threshold cycles (Ct), i.e. the 
number of cycles at which the fluorescent signal of the reaction 
crosses a pre-determined threshold value. Since standard quanti- 
fication methods (including normalization by housekeeping genes) 
introduce a considerable amount of experimental noise for very 
lowly expressed genes, raw Ct  values were used to perform an 
absolute quantification of KCNK9 and SLC2A10 transcripts. As 
negative controls, housekeeping genes (HPRT1, GAPDH) were 
also tested for parent-origin-effect to exclude the possibility that 
the  observed difference in  KCNK9  and  SLC2A10  expression 
levels was due to the sample preparation process. Raw Ct values 
were  inverse-normal quantile  transformed  and  a  linear  mixed 
model  was  fitted  (using the  R  function  lmer)  modelling  the 
technical replicates as random effects and parental origin as a fixed 
effect. 
 
Supporting Information 
 
Figure  S1    QQ-plot  of  the  POE  test  P-values for  SNPs  in 
imprinted regions (left) and for the whole genome (right). 
(PNG) 
 
Figure S2  Left hand side plots describe SNP-methylation 
associations (mQTLs), where each point is a methylation probe. 
X-axis represents their physical position and  y-axis the 2log10 
association P-value with the target SNP, whose location is 
indicated by the dashed line. Note that rs3092611 was used as a 
proxy for rs3091869 (r2 = 0.998). The  corresponding  QQ-plots 
appear on the right hand side. Neighbouring methylation probes 
are strongly correlated therefore expected P-values were computed 
by estimating the effective number of tests For expected P-values 
we computed the effective number of tests [33]. 
(PNG) 
Figure S3    Left hand side plots describe methylation associations 
with  BMI  in  MZ  twins. Each  point  is a  methylation  probe, 
X-axis represents their physical position and  y-axis the 2log10 
association P-value with  BMI.  Location  of the  target  SNP  is 
indicated by the dashed line. Note that rs3092611 was used as a 
proxy for rs3091869 (r2 = 0.998). The  corresponding  QQ-plots 
appear on the right hand side. Neighbouring methylation probes 
are strongly correlated therefore expected P-values were computed 
by estimating the effective number of tests For expected P-values 
we computed the effective number of tests [33]. 
(PNG) 
Figure S4  POE  association results for previously reported 
imprinted BMI linkage regions. Second dashed line corresponds 
to the Benjamini-Hochberg 5% FDR threshold. 
(PNG) 
 
Figure S5    POE  association P-value QQ-plot  for the  top  58 
independent SNPs with marginal BMI-association P-value ,1025 
in Speliotes et al. [10]. 
(PNG) 
Table S1    Description of the BMI distribution in the participat- 
ing cohorts. 
(XLSX) 
Table S2    Brief summary of the participating cohorts. 
(XLSX) 
Table S3  Information on the genotyping methods in the 
participating cohorts. 
(XLSX) 
Table S4    Replication of the 6 discovery SNPs in family studies. 
Extended version of Table 2. 
(XLSX) 
Table S5    Parental  asymmetry test results for our 6 candidate 
SNPs in adolescent population. 
(XLSX) 
Table S6    Analysis of the effect of gender- and  age-correction 
and phenotype transformations on the POE association results. 
(XLSX) 
Table S7    Genotyping results and parental allele determination 
for members of the CEPH families. 
(XLSX) 
Table S8    Association results between methylation- and  BMI- 
differences among MZ twins of the TwinsUK study. 
(XLSX) 
Table S9    POE association P-values for the 32 SNPs associated 
with BMI in the largest-to-date meta-analysis [10]. 
(XLSX) 
 
Table S10    POE association P-values for the top 58 independent 
SNPs with BMI-association P-value ,1025  in the largest-to-date 
meta-analysis [10]. 
(XLSX) 
Data S1    Supporting information contain text on the expression- 
and  methylation analysis, the  effective  sample size derivation in 
mother-offspring  vs  trio  studies, POE  look-ups for  SNPs  with 
marginal BMI association, study descriptions and acknowledgements. 
(DOCX)
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